|
EP4096651A4
(en)
|
|
Compounds and uses thereof
|
|
EP4096664A4
(en)
|
|
Compounds and uses thereof
|
|
EP4203952A4
(en)
|
|
Heterocyclic compounds and uses thereof
|
|
EP4096668A4
(en)
|
|
Compounds and uses thereof
|
|
CA3261681A1
(en)
|
|
Heterocyclic compounds and uses thereof
|
|
EP4247815A4
(en)
|
|
Compounds and uses thereof
|
|
EP4071155A4
(en)
|
|
Thiazololactam compound as erk inhibitor and use thereof
|
|
EP4419511A4
(en)
|
|
Compounds and their uses as gpr183 inhibitors
|
|
EP4326696A4
(en)
|
|
Heterocyclic compounds and uses thereof
|
|
AU2022300316A1
(en)
|
|
Novel compounds and their use
|
|
EP4337211A4
(en)
|
|
Compounds and uses thereof
|
|
HK40090096A
(en)
|
|
Compounds and their uses as mif inhibitors
|
|
EP4330228A4
(en)
|
|
G-alpha-s inhibitors and uses thereof
|
|
EP4393921A4
(en)
|
|
Nalidinone compound as fgfr4 inhibitor and use thereof
|
|
HK40114341A
(en)
|
|
Compounds and their uses as gpr183 inhibitors
|
|
CA3287411A1
(en)
|
|
Compounds and their uses as gpr183 inhibitors
|
|
HK40111947A
(en)
|
|
Egfr-cmet-targeted compounds and uses thereof
|
|
HK40114381A
(en)
|
|
Macromolecule-supported 8-sulfonyl-benzazepine compounds and their uses
|
|
HK40080938A
(en)
|
|
Compounds and uses thereof
|
|
HK40109568A
(en)
|
|
Compounds and their uses as cd38 inhibitors
|
|
AU2024322209A1
(en)
|
|
Compounds and uses
|
|
HK40086534A
(en)
|
|
Improved anti-senescence compounds and uses thereof
|
|
CA3270830A1
(en)
|
|
Compounds and uses thereof
|
|
HK40123856A
(en)
|
|
Compounds and uses thereof
|
|
HK40114337A
(en)
|
|
Irhom2 inhibitors and uses thereof
|